Seed · Biotech · Geneva, Switzerland · Founded 2021 · 5–15 employees
FluoSphera is a Geneva-based biotech startup that has developed a groundbreaking multiplexed in vitro platform enabling simultaneous testing of up to 6-7 human tissue models in a single well to predict drug efficacy and toxicity. The company addresses the critical problem that over 90% of drug candidates fail in clinical trials, costing billions in development. Their patented technology provides human-relevant alternatives to animal testing and helps pharmaceutical companies achieve estimated savings of €85-428 million per drug molecule. Recently raised €1.23 million led by Soulmates Ventures with participation from IndieBio New York.
No open roles listed right now.